Clinical Study Protocol - Debris Interventional Removal in ACS (DESIRE-ACS)
NCT02325869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2015-07-28
Summary
DebriS Interventional REmoval in ACS (DESIRE-ACS) Study to assess the safety and performance of the ECA Bell balloon in subjects undergoing coronary percutaneous interventions.
Conditions
- Coronary Disease
- Acute Coronary Syndrome
- Coronary Occlusion
Interventions
- DEVICE
-
Bell Balloon Catheter
An angioplasty procedure to open the blockage in blood vessels will be performed. Standard angioplasty procedure includes local analgesia of the groin area and a small cut through which the procedure will be performed. An introducer sheath (thin tube) will be inserted. The Bell Balloon dilatation will then be inserted. The Bell Balloon works in fashion similar to standard balloon with the same physical and behavioral characteristics. Upon deflation, debris from the blockage is withdrawn into the cavity formed between the deflated balloon and its outer capsule. Then balloon is retracted and retrieved through the guiding catheter, together with the captured debris and trap it between the outer surface of the balloon and the inner surface of the membrane.
Sponsors & Collaborators
-
Angioslide Ltd.
lead INDUSTRY
Principal Investigators
-
Giora Weisz, Prof. M.D · Chairman, Department of Cardiology. Shaare Zedek Medical Center, Jerusalem Israel
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone
NCT07038408 ·Status: RECRUITING ·Phase: NA
-
Coronary Laser Atherectomy Registry From an International Taskforce
NCT07348341 ·Status: NOT_YET_RECRUITING
-
Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions
NCT00233714 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
NCT05033964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis
NCT03529006 ·Status: UNKNOWN ·Phase: NA
-
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893 ·Status: RECRUITING ·Phase: NA
-
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
NCT00231257 ·Status: COMPLETED ·Phase: PHASE3
-
Cutting Balloon Predilation Prior to Abluminus Sirolimus-eluting Stent Implantation (CUT-DRESS).
NCT05801003 ·Status: RECRUITING ·Phase: NA
-
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
NCT00279006 ·Status: UNKNOWN ·Phase: NA
-
Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty
NCT04885816 ·Status: TERMINATED ·Phase: NA
-
DESolve Post-Approval Study
NCT02013349 ·Status: COMPLETED ·Phase: NA
-
Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES
NCT02367495 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)
NCT04937803 ·Status: COMPLETED ·Phase: NA
-
The PREVAIL Study
NCT03260517 ·Status: COMPLETED ·Phase: NA
-
SELUTION 4 De Novo Small Vessel IDE Trial
NCT05946629 ·Status: RECRUITING ·Phase: NA
-
Rise Semi Compliant Balloon Study in Patient With CAD
NCT04796038 ·Status: COMPLETED ·Phase: NA
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
The All-comers Sirolimus-coated Balloon European Registry
NCT03085823 ·Status: COMPLETED
-
Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
NCT00232739 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
NCT06345209 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
BIOFLOW III Satellite-Italy Orsiro Stent System
NCT02028728 ·Status: COMPLETED
-
EXCELLA Post-Approval Study
NCT02009956 ·Status: COMPLETED ·Phase: NA
-
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524 ·Status: RECRUITING ·Phase: NA
-
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon
NCT03242096 ·Status: COMPLETED ·Phase: NA
-
The Clinical Efficacy and Safety of Drug-coated Balloon
NCT05133921 ·Status: COMPLETED